Cations in the human blood serum

Uspekhi Fiziologicheskikh Nauk

Volumn 36, Issue 3, 2005, Pages 3-32

  Kutina, A V ^a   Kuznetsova, A A ^a   Natochin, Yu V ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CATION;

AGE; BLOOD; CHILD; DRUG EFFECT; ELECTROLYTE BALANCE; GENERAL ASPECTS OF DISEASE; HUMAN; INFANT; NEWBORN; OSMOLARITY; PHYSIOLOGY; PRESCHOOL CHILD; REVIEW;

AGE FACTORS; CATIONS; CHILD; CHILD, PRESCHOOL; DISEASE; HUMANS; INFANT; INFANT, NEWBORN; OSMOLAR CONCENTRATION; WATER-ELECTROLYTE BALANCE;

EID: 27744540374     PISSN: 03011798     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (469)

1. Abraham A.S., Rosenman D., Meshulam Z. et al. Serum, lymphocyte, and erythrocyte potassium, magnesium, and calcium concentrations and their relation to tachyarrhythmias in patients with acute myocardial infarction // Am. J. Med. 1986. V. 81. No 6. P. 983-988.
2. Alamouidi O.S. Electrolyte disturbances in patients with chronic, stable asthma: effect of therapy // Chest. 2001. V. 120. No 2. P. 431-436.
3. Al-Kudsi R.R., Daugirdas J.T., Ing T.S. et al. Extreme hyperglycemia in dialysis patients // Clin. Nephrol. 1982. V. 17. No 5. P. 228-231.
4. Amede F.J., James K.A., Michelis M.F., Gleim G.W. Changes in serum sodium, sodium balance, water balance, and plasma hormone levels as the result of pelvic surgery in women // Int. Urol. Nephrol. 2002-2003. V. 34. No 4. P. 545-550.
5. Amitai Y., Lovejoy F.H., Jr. Hypokalemia in acute theophylline poisoning // Am. J. Emerg. Med. 1988. V. 6. No 3. P. 214-218.
6. Andersen L.J., Andersen J.L., Pump B., Bie P. Natriuresis induced by mild hypernatremia in humans // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002. V. 282. No 6. P. R1754-R1761.
7. Antunes-Rodrigues J., De Castro M., Elias L.K. et al. Neuroendocrine control of body fluid metabolism // Physiol. Rev. 2004. V. 84. P. 169-208.
8. Arias-Reyes J.A., Matos-Martinez M., Velasquez-Jones L., Dubey-Ortega L.A. Correccion de la hiperkalemia con salbutamol endovenoso en ninos con insuficiencia renal cronica // Bol. Med. Hosp. Infant. Mex. 1989. V. 46. No 9. P. 603-606.
9. Ariceta G., Rodriguez-Soriano J., Vallo A. Renal magnesium handling in infants and children // Acta Paediatr. 1996. V. 85. No 9. P. 1019-1023.
10. Arieff A.I., Ayus J.C. Endometrial ablation complicated by fatal hyponatremic encephalopathy // JAMA. 1993. V. 270. No 10. P. 1230-1232.
11. Arieff A.I., Ayus J.C., Fraser C.L. Hyponatraemia and death or permanent brain damage in healthy children // BMJ. 1992. V. 304. No 6836. P. 1218-1222.
12. Arnold W.C. Efficacy of metolazone and furosemide in children with furosemide-resistant edema // Pediatrics. 1984. V. 74. No 5. P. 872-875.
13. Aronson D., Dragu R.E., Nakhoul F. et al. Hyponatremia as a complication of cardiac catheterization: a prospective study // Am. J. Kidney Dis. 2002. V. 40. No 5. P. 940-946.
14. Ashkenazi S., Dinari G., Zevulunov A., Nitzan M. Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children // Am. J. Dis. Child. 1987. V. 141. No 2. P. 208-210.
15. Aslam S., Friedman E.A., Ifudu O. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients // Nephrol. Dial. Transplant. 2002. V. 17. No 9. P. 1639-1642.
16. Ayus J.C., Arieff A.I. Glycine-induced hypo-osmolar hyponatremia // Arch. Intern. Med. 1997. V. 157. No 2. P. 223-226.
17. Baajafer F.S., Hammami M.M., Mohamed G.E. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism // J. Endocrinol. Invest. 1999. V. 22. No 1. P. 35-39.
18. Barr S.I., Costill D.L., Fink W.J. Fluid replacement during prolonged exercise: effects of water, saline, or no fluid // Med. Sci. Sports Exerc. 1991. V. 23. No 7. P. 811-817.
19. Batton D.G., Maisels M.J., Shulman G. Serum potassium changes following packed red cell transfusions in newborn infants // Transfusion. 1983. V. 23. No 2. P. 163-164.
20. Benchetrit S., Bernheim J., Podjarny E. Normokalemic hyperaldosteronism in patients with resistant hypertension // Isr. Med. Assoc. J. 2002. V. 4. No 1. P. 17-20.
21. Bennish M.L., Azad A.K., Yousefzadeh D. Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome // Gastroenterology. 1991. V. 101. No 3. P. 626-634.
22. Bisset G.W., Chowdrey H.S. Control of release of vasopressin by neuroendocrine reflexes // Q. J. Exp. Physiol. 1988. V. 73. P. 811-872.
23. Blake J., Devereux R.B. Differential effects of direct antagonism of AII compared to ACE inhibitors on serum potassium levels and azotemia in patients with severe congestive heart failure // Congest. Heart Fail. 2000. V. 6. No 4. P. 193-196.
24. Blumberg A., Roser H.W., Zehnder C., Muller-Brand J. Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium // Nephrol. Dial. Transplant. 1997. V. 12. No 8. P. 1629-1634.
25. Blumberg A., Weidmann P., Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure // Kidney Int. 1992. V. 41. No 2. P. 369-374.
26. Blumberg A., Weidmann P., Shaw S., Gnadinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure // Am. J. Med. 1988. V. 85. No 4. P. 507-512.
27. Bobkowski W., Siwinska A., Zachwieja J. et al. Zaburzenia elektrolitowe i arytmia komorowa u dzieci z pierwotnym wypadaniem platkow zastawki dwudzielnej // Pol. Merkuriusz. Lek. 2001. V. 11. No 62. P. 125-128.
28. Bock K.D., Nitzsche T. Laxantienabusus, Plasma-Kalium und chronische interstitielle Nephritis durch Phenacetinabusus // Klin. Wochenschr. 1976. V. 54. No 5. P. 239-241.
29. Bodenhamer J., Berstrom R., Brown D. et al. Frequetly nebulized beta-agonists for asthma // Ann. Emerg. Med. 1992. V. 21. No 11. P. 1337-1342.
30. Boncimino K., McMahon D.J., Addesso V. et al. Magnesium deficiency and bone loss after cardiac transplantation // J. Bone Miner. Res. 1999. V. 14. No 2. P. 295-303.
31. Bouillon T., Meineke I., Port R. et al. Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age // Eur. J. Clin. Pharmacol. 1996. V. 51. No 2. P. 153-160.
32. Brion L.P., Schwartz G.J., Campbell D., Fleischman A.R. Early hyperkalaemia in very low birth-weight infants in the absence of oliguria // Arch. Dis. Child. 1989. V. 64. No 2. P. 270-272.
33. Brown K.A., Bissonnette B., McIntyre B. Hyperkalaemia during rapid blood transfusion and hypovolaemic cardiac arrest in children // Can. J. Anaesth. 1990. V. 37. No 7. P. 747-754.
34. Bruck E. Seasonal incidence of hypertonic dehydration in diarrhea of infant // Am. J. Dis. Child. 1969. V. 118. P. 582-584.
35. Bruck E., Abul G., Aceto T., Buffalo. Pathogenesis and pathophysiology of hypertonic dehydration with diarrhea // Am. J. Dis. Child. 1968. V. 115. P. 122-143.
36. Bundgaard H., Kjeldsen K., Suarez K.K. et al. Endotoxemia stimulates skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans // Am. J. Physiol. Heart Circ. Physiol. 2003. V. 284. No 3. P. H1028-H1034.
37. Burhanoglu M., Tutuncuoglu S., Coker C. et al. Hypozincaemia in febrile convulsion // Eur. J. Pediatr. 1996. V. 155. No 6. P. 498-501.
38. Burnakis T.G., Mioduch H.J. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia // Arch. Int. Med. 1984. V. 144. No 12. P. 2371-2372.
39. Butler J.V., McAvoy H., McEnroy D., Mulkerrin E.C. Spironolactone therapy in older patients - the impact of renal dysfunction // Arch. Gerontol. Geriatr. 2002. V. 35. No 1. P. 45-49.
40. Canuso C.M., Goldman M.B. Does minimizing neuruleptic dosage influence hyponatremia? // Psychiatry Res. 1996. V. 63. No 2-3. P. 227-229.
41. Ceremuzynski L., Van Hao N. Ventricular arrhythmias late after myocardial infarction are related to hypomagnesemia and magnesium loss: preliminary trial of corrective therapy // Clin. Cardiol. 1993. V. 16. No 6. P. 493-496.
42. Chamontin B., Begasse F., David D., Salvador M. Effet d'un inhibiteur calcique, la nicardipine, sur la secretion de l'aldosterone au cours de l'hyperaldosteronisme primaire // Arch. Mal. Coeur. Vaiss. 1989. V. 82. No 7. P. 1237-1240.
43. Chamontin B., Blanchouin-Emeric N., Amar J. et al. Precurseurs de l'aldosterone et hypertension arterielle avec hypokaliemie et nodule surrenalien, non attribuee a un hyperaldosteronisme primaire // Arch. Mal. Coeur. Vaiss. 1996. V. 89. No 8. P. 1055-1058.
44. Cheng J.C., Zikos D., Skopicki H.A. et al. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction // Am. J. Med. 1990. V. 88. No 6. P. 561-566.
45. Cho M.S., Lee K.S., Lee Y.K. et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate // Korean J. Int. Med. 2002. V. 17. No 2. P. 114-121.
46. Cholst I.N., Steinberg S.F., Tropper P.J. et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects // N. Engl. J. Med. 1984. V. 310. No 19. P. 1221-1225.
47. Clark B.A., Brown R.S., Epstein F.H. Effect of atrial natriuretic peptide on potassium-stimulated aldosterone secretion: potential relevance to hypoaldosteronism in man // J. Clin. Endocrinol. Metab. 1992. V. 75. No 2. P. 399-403.
48. Clark B.A., Shannon C., Brown R.S., Gervino E.V. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease // J. Am. Soc. Nephrol. 1996. V. 7. No 8. P. 1223-1227.
49. Clive D.M., Gurwitz J.H., Rossetti R.G. Potassium homeostasis with indomethacin therapy in normal subjects // Am. J. Kidney Dis. 1992. V. 19. No 1. P. 16-21.
50. Colle E., Ayoub E., Raile R. Hypertonic dehydration the role of feedings hig in solutes. // Pediatrics. 1958. V. 22. No 1. P. 5-12.
51. Colussi G., Rombola G., De Ferrari M.E. et al. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome // Am. J. Nephrol. 1994. V. 14. No 2. P. 127-135.
52. Coma-Canella I. Changes in plasma potassium during the dobutamine stress test // Int. J. Cardiol. 1991. V. 33. No 1. P. 55-59.
53. Comprehensive human physiology / Eds. Greger R., Windhorst U. Berlin, Heidelberg: Springer, 1996. V. 2. 2527 p.
54. Contreras G., Garces G., Reich J. et al. Predictors of alkalosis after liver transplantation // Am. J. Kidney Dis. 2002. V. 40. No 3. P. 517-524.
55. Costarino A.T., Baumgart S., Norman M.E., Polin R.A. Renal adaptation to extrauterine life in patients with respiratory distress syndrome // Am. J. Dis. Child. 1985. V. 139. No 10. P. 1060-1063.
56. Craven P.C., Gremillion D.H. Risk factors of ventricular fibrillation during rapid amphotericin B infusion // Antimicrob. Agents Chemother. 1985. V. 27. No 5. P. 868-871.
57. Cunningham J., Segre G.V., Slatopolsky E., Avioli L.V. Effect of heavy exercise on mineral metabolism and calcium regulating hormones in humans // Calcif. Tissue Int. 1985. V. 37. No 6. P. 598-601.
58. Cupisti A., Rizza G.M., D'Alessandro C. et al. Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients // Biomed. Pharmacother. 2003. V. 57. No 3-4. P. 169-172.
59. Czajkowski K., Wojcicka-Bentyn J., Grymowicz M. et al. Calcium-phosphorus-magnesium homeostasis in pregnant women after renal transplantation // Int. J. Gynaecol. Obstet. 2003. V. 80. No 2. P. 111-116.
60. Dahlenburg G.W., Burnell R.H., Braybrook R. The relation between cord serum sodium levels in newborn infants and maternal intravenous therapy during labour // Br. J. Obstet. Gynaecol. 1980. V. 87. No 6. P. 519-522.
61. Danielides I.C., Mellow M.H. Effect of acute hypercalcemia on human esophageal motility // Gastroenterology. 1978. V. 75. No 6. P. 1115-1119.
62. Davies D.P. Plasma osmolality and feeding practices of healthy infant in first three months of life // Br. Med. J. 1973. No 3. P. 340-342.
63. Davies J.S., Hinds N.P., Millward E.M. et al. Hypokalaemia during insulin-induced hypoglycaemia in hypopituitary adults with and without growth hormone deficiency // Clin. Endocrinol. (Oxf). 1998. V. 49. No 2. P. 217-220.
64. Davis T.M., Pukrittayakamee S., Woodhead J.S. et al. Calcium and phosphate metabolism in acute falciparum malaria // Clin. Sci. (Lond). 1991. V. 81. No 3. P. 297-304.
65. Day G.M., Radde I.C., Balfe J.W., Chance G.W. Electrolyte abnormalities in very low birthweight infants // Pediatr. Res. 1976. V. 10. No 5. P. 522-526.
66. De Gasparo M., Catt K.J., Inagami T. Et al. International union of pharmacology. XXIII. The angiotensin II receptors // Pharmacol. Rev. 2000. V. 52. P. 415-472.
67. De Kieviet W., Slaats E.H., Abeling N.G. Pediatric reference values for calcium, magnesium and inorganic phosphorus in serum obtained from Bhattacharya plots for data from unselected patients // J. Clin. Chem. Clin. Biochem. 1986. V. 24. No 4. P. 233-242.
68. Decaux G. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985 // J. Lab. Clin. Med. 2001. V. 138. No 1. P. 18-21.
69. Decaux G., Prospert F., Namias B., Soupart A. Effect of urea and indomethacin intake on solute excretion in the syndrome of inappropriate secretion of antidiuretic hormone // Nephron. 1993. V. 64. No 1. P. 47-52.
70. Decaux G., Unger J., Brimioulle S., Mockel J. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy // JAMA. 1982. V. 247. No 4. P. 471-474.
71. DeFronzo R.A., Taufield P.A., Black H. et al. Impaired renal tubular potassium secretion in sickle cell disease // Ann. Intern. Med. 1979. V. 90. No 3. P. 310-316.
72. Derubertis F.R., Michelis M.F., Bloom M.E. et al. Impaired water excretion in myxedema // Am. J. Med. 1971. V. 51. No 1. P. 41-53.
73. Dhawan A., Narang A., Singhi S. Hyponatraemia and the inappropriate ADH syndrome in pneumonia // Ann. Trop. Paediatr. 1992. V. 12. No 4. P. 455-462.
74. DiBona G.F., Kopp U.C. Neural control of renal function // Physiol. Rev. 1997. V. 238. P. F26-F30.
75. DiBona G.F. Neural control of the kidney: functionally specific renal sympathetic nerve fibers // Am. J. Physiol. Renal Physiol. 2000. V. 279. P. F1517-F1524.
76. Diederich S., Franzen N.F., Bahr V., Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases // Eur. J. Endocrinol. 2003. V. 148. No 6. P. 609-617.
77. Dincsoy M.Y., Tsang R.C., Laskarzewski P. et al. Serum calcitonin response to administration of calcium in newborn infant during exchange blood transfusion // J. Pediatr. 1982. V. 100. No 5. P. 782-786.
78. Dolson G.M., Ellis K.J., Bernardo M.V. et al. Acute decreases in serum potassium augment blood pressure // Am. J. Kidney Dis. 1995. V. 26. No 2. P. 321-326.
79. Don B.R. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects // Clin. Nephrol. 2001. V. 55. No 1. P. 45-52.
80. Donovan E.F., Tsang R.C., Steichen J.J. et al. Neonatal hypermagnesemia: Effect on parathyroid hormone and calcium homeostasis // J. Pediatr. 1980. V. 96. No 2. P. 305-310.
81. Drayer J.I., Kloppenborg P.W., Festen J. et al. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension // Am. J. Cardiol. 1975. V. 36. No 5. P. 716-721.
82. Eibl N.L., Kopp H.P., Nowak H.R. et al. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy // Diabetes Care. 1995. V. 18. No 2. P. 188-192.
83. Elisaf M., Liberopoulos E., Bairaktari E., Siamopoulos K. Hypokalaemia in alcoholic patients // Drug Alcohol. Rev. 2002. V. 21. No 1. P. 73-76.
84. Engle W.D., Arant B.S., Jr. Urinary potassium excretion in thecritically ill neonate // Pediatrics. 1984. V. 74. No 2. P. 259-264.
85. English M.C., Waruiru C., Lightowler C. et al. Hyponatraemia and dehydration in severe malaria // Arch. Dis. Child. 1996. V. 74. No 3. P. 201-205.
86. Fabregas N., Taura P., Castillo J. et al. Hypokalemic effect of salbutamol administered intravenously in the preoperative period // Rev. Esp. Anestesiol. Reanim. 1989. V. 36. No 3. P. 149-152.
87. Fajardo J.E., Stafford E.M., Bass J.W. et al. Inappropriate antidiuretic hormone in children with viral meningitis // Pediatr. Neurol. 1989. V. 5. No 1. P. 37-40.
88. Farge D., Pagny J.Y., Chatellier G. et al. Corticosurrenalomes malins reveles par un tableau isole d'hyperaldosteronisme primaire // Arch. Mal. Coeur. Vaiss. 1988. V. 81. Spec. No. P. 83-87.
89. Fatemi S., Ryzen E., Flores J. et al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism // J. Clin. Endocrinol. Metab. 1991. V. 73. No 5. P. 1067-1072.
90. Fernandez J.A., Lopez P., Orozco D., Merino J. Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain // Eur. J. Clin. Microbiol. Infect. Dis. 2002. V. 21. No 10. P. 729-735.
91. Finer G., Shalev H., Birk O.S. et al. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome // J. Pediatr. 2003. V. 42. No 3. P. 318-323.
92. Fiser R.T., Torres A.J., Butch A.W., Valentine J.L. Ionized magnesium concentrations in critically ill children // Crit. Care Med. 1998. V. 26. No 12. P. 2048-2052.
93. Fisher B.M., Thomson I., Hepburn D.A., Frier B.M. Effects of adrenergic blockade on serum potassium changes in response to acute insulin-induced hypoglycemia in nondiabetic humans // Diabetes Care. 1991. V. 14. No 7. P. 548-552.
94. Flad T.M., Conway J.D., Cunningham S.K., McKenna T.J. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency // Clin. Endocrinol. (Oxf). 1996. V. 45. No 5. P. 529-534.
95. Fletcher G.F., Fletcher B.J., Sweeney U.E. Effects of exercise testing, training and beta blockade on serum potassium in normal subjects // Am. J. Cardiol. 1990. V. 65. No 18. P. 1242-1245.
96. Foo K., Sekhri N., Deaner A. et al. Effect of diabetes on serum potassium concentrations in acute coronary syndromes // Heart. 2003. V. 89. No 1. P. 31-35.
97. Forrest J.N., Cox M., Hong C. et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone // N. Engl. J. Med. 1978. V. 298. No 4. P. 173-177.
98. Franci C.R., Kozlowski G.P., McCann S.M. Water intake in rats subjected to hypothalamic immunoneutralization of angiotensin II, atrial natriuretic peptide, vasopressin, or oxytocin // Proc. Natl. Acad. Sci. USA. 1989. V. 86. P. 2952-2956.
99. Franck H., Beuker F., Gurk S. The effect of physical activity on bone turnover in young adults // Exp. Clin. Endocrinol. 1991. V. 98. No 1. P. 42-46.
100. Frankel H., Haskell R., Lee S.Y. et al. Hypomagnesemia in trauma patients // World J. Surg. 1999. V. 23. No 9. P. 966-969.
101. Franz M.N., Segar W.E. The association of various factors and hypernatremic diarrheal dehydration // Am. J. Dis. Child. 1959. V. 97. No 3. 298-302.
102. Friedberg C.E., van Buren M., Bijlsma J.A., Koomans H.A. Insulin increases sodium reabsorption in diluting segment in humans: evidence for indirect mediation through hypokalemia // Kidney Int. 1991. V. 40. No 2. P. 251-256.
103. Fukuda Y., Kojima T., Ono A. et al. Factors causing hyperkalemia in premature infants // Am. J. Perinatol. 1989. V. 6. No 1. P. 76-79.
104. Gabow P.A., Moore S., Schrier R.W. Spironolactone-induced hyperchloremic acidosis in cirrhosis // Ann. Intern. Med. 1979. V. 90. No 3. P. 338-340.
105. Gadano A., Moreau R., Pessione F. et al. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis // J. Hepatol. 2000. V. 32. No 1. P. 38-42.
106. Galun E., Tur-Kaspa I., Assia E. et al. Hyponatremia induced by exercise: a 24-hour endurance march study // Miner. Electrolyte Metab. 1991. V. 17. No 5. P. 315-320.
107. Garcia-Ortiz R., Milovic I., Uribe C., Gomez M. Niveles de magnesio Plasmatico y eritrocitario en pacientes en dialisis cronica // Rev. Med. Chil. 1989. V. 117. No 5. P. 544-548.
108. Gastaldelli A., Emdin M., Conforti F. et al. Insulin prolongs the QTc interval in humans // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000. V. 279. No 6. P. R2022-R2025.
109. Giacoia G.P., Miranda R., West K.I. Measured vs calculated plasma osmolality in infants with very low birth weights // Am. J. Dis. Child. 1992. V. 146. N. 6. P. 712-717.
110. Gifford J.D., Rutsky E.A., Kirk K.A., McDaniel H.G. Control of serum potassium during fasting in patients with end-stage renal disease // Kidney Int. 1989. V. 35. No 1. P. 90-94.
111. Gill G.V., Baylis P.H., Flear C.T., Lawson J.Y. Changes in plasma solutes after food // J. R. Soc. Med. 1985. V. 78. No 12. P. 1009-1013.
112. Green K.W., Key T.C., Coen R., Resnik R. The effects of maternally administered magnesium sulfate on the neonate // Am. J. Obstet. Gynecol. 1983. V. 146. No 1. P. 29-33.
113. Greenberg S., Reiser I.W., Chou S.Y., Porush J.G. Trimethoprim- sulfamethoxazole induces reversible hyperkalemia // Ann. Int. Med. 1993. V. 119. No 4. P. 291-295.
114. Greer F.R., Tsang R.C., Levin R.S. et al. Increasing serum calcium and magnesium concentrations in breast-fed infants: longitudinal studies of minerals in human milk and sera of nursing mothers their infants // J. Pediatr. 1982. V. 100. No 1. P. 59-64.
115. Gruskay J., Costarino A.T., Polin R.A., Baumgart S. Nonoliguric hyperkalemia in the premature infant weighing less than 1000 grams // J. Pediatr. 1988. V. 113. No 2. P. 381-386.
116. Haag-Weber M., Schollmeyer P., Horl W.H. Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporin // Miner. Electrolyte Metab. 1990. V. 16. No 1. P. 66-68.
117. Hainsworth J.D., Workman R., Greco F.A. Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer // Cancer. 1983. V. 51. No 1. P. 161-165.
118. Handwerker S.M., Altura B.T., Altura B.M. Ionized serum magnesium and potassium levels in pregnant women with preeclampsia and eclampsia // J. Reprod. Med. 1995. V. 40. No 3. P. 201-208.
119. Handwerker S.M., Altura D.T., Royo B., Altura B.M. Ionized serum magnesium levels in umbilical cord blood of normal pregnant women at delivery: relationship to calcium, demographics, and birthweight // Am. J. Perinatol. 1993. V. 10. No 5. P. 392-397.
120. Hanna S., Tibby S.M., Durward A. et al. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis // Acta Paediatr. 2003. V. 92. No 4. P. 430-434.
121. Hariprasad M.K., Eisingcr R.P., Nadler I.M. et al. Hyponatremia in psychogenic polydipsia // Arch. Intern. Med. 1980. V. 140. No 12. P. 1639-1642.
122. Harkavy K.L., Scanlon J.W. Hypernatremia in the very low birthweight infant // Int. J. Pediatr. Nephrol. 1983. V. 4. No 2. P. 75-78.
123. Haselton J.R., Vari R.C. Neuronal cell bodies in paraventricular nucleus affect renal hemodynamics and excretion via the renal nerves // Am. J. Physiol. Renal Physiol. 1998. V. 275. P. F1334-F1342.
124. Hashimoto Y., Nishimura Y., Maeda H., Yokoyama M. Assessment of magnesium status in patients with bronchial asthma // J. Asthma. 2000. V. 37. No 6. P. 489-496.
125. Hene R.J., Koomans H.A., Dorhout Mees E.J. et al. Correction of hypokalemia in Bartter's syndrome by enalapril // Am. J. Kidney Dis. 1987. V. 9. No 3. P. 200-205.
126. Higham P.D., Adams P.C., Murray A., Campbell R.W. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study // Q. J. Med. 1993. V. 86. No 9. P. 609-617.
127. Hillman L., Schlotzhauer C., Lee D. et al. Decreased bone mineralization in children with phenylketonuria under treatment // Eur. J. Pediatr. 1996. V. 155. Suppl. 1. P. 148-152.
128. Hollifield J.W. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy // Am. J. Med. 1986. V. 80. No 4A. P. 8-12.
129. Hollifield J.W., Slaton P.E. Thiazide diuretics, hypokalemia and cardiac arrhythmias // Acta Med. Scand. 1981. V. 647. Suppl. P. 67-73.
130. Hosomi H., Morita H. Hepatorenal and hepatointestinal reflexes in sodium homeostasis // News Physiol. Sci. 1996. V. 11. P. 103-107.
131. Howse M., Sastry S., Bell G.M. Changes in the corrected QT interval and corrected QT dispersion during haemodialysis // Postgrad. Med. J. 2002. V. 78. No 919. P. 273-275.
132. Huang Y.Y., Hsu B.R., Tsai J.S. Paralytic myopathy - a leading clinical presentation for primary aldosteronism in Taiwan // J. Clin. Endocrinol. Metab. 1996. V. 81. No 11. P. 4038-4041.
133. Hugen C.A., Oudesluys Murphy A.M., Hop W.C. Serum sodium levels and probability of recurrent febrile convulsions // Eur. J. Pediatr. 1995. V. 154. No 5. P. 403-405.
134. Hulting J. In-hospital ventricular fibrillation and its relation to serum potassium // Acta Med. Scand. 1980. V. 647. No 7. Suppl. P. 109-116.
135. Hung C.H., Chu D.M., Wang C.L., Yang K.D. Hypokalemia and salbutamol therapy in asthma // Pediatr. Pulmonol. 1999. V. 27. No 1. P. 27-31.
136. Hurley J.K. Symptomatic hyponatremia in nephrotic syndrome // Am. J. Dis. Child. 1980. V. 134. No 2. P. 204-206.
137. Husmann M.J., Fuchs P., Truttmann A.C. et al. Extracellular magnesium depletion in pediatric patients with insulin-dependent diabetes mellitus // Miner. Electrolyte Metab. 1997. V. 23. No 2. P. 121-124.
138. Hussain S., Dreyfus D.E., Marcus R.J. et al. Is spironolactone safe for dialysis patients? // Nephrol. Dial. Transplant. 2003. V. 18. No 11. P. 2364-2368.
139. Hymes L.C., Warshaw B.L. Thiazide diuretics for the treatment of children with idiopathic hypercalciuria and hematuria // J. Urol. 1987. V. 138. No 5. P. 1217-1219.
140. Ilves P., Kiisk M., Soopold T., Talvik T. Serum total magnesium and ionized calcium concentrations in asphyxiated term newborn infants with hypoxic-ischaemic encephalopathy // Acta Paediatr. 2000. V. 89. No 6. P. 680-685.
141. Inaguma D., Kitagawa W., Hayashi H. et al. Three cases of severe hyponatremia under taking selective serotonin reuptake inhibitor (SSRI) // Nippon Jinzo Gakkai Shi. 2000. V. 42. No 8. P. 644-648.
142. Inoue K., Tadai T., Kamimura H. et al. The syndrome of self-induced water intoxication in psychiatric patients // Folia Psychiatr. Neurol. Jpn. 1985. V. 39. No 2. P. 121-127.
143. Ironside A.G., Tuxford A.E., Heyworth B.A. Survey of infantile gastroenteritis // Br. Med. J. 1970. No 3. P. 20-24.
144. Irving R.A., Noakes T.D., Buck R. et al. Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia // J. Appl. Physiol. 1991. V. 70. No 1. P, 342-348.
145. Isezuo S.A., Ekele B.A. Eclampsia and abnormal QTc // West Afr. J. Med. 2004. V. 23. No 2. P. 123-127.
146. Ishikawa S., Saito T., Okada K. et al. Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism // Endocrinol. Jpn. 1985. V. 32. No 6. P. 793-802.
147. Ishikawa S., Sakuma N., Fujisawa G. et al. Opposite changes in serum sodium and potassium in patients in diabetic coma // Endocr. J. 1994. V. 41. No 1. P. 37-43.
148. Iwasaki Y., Oiso Y., Takatsuki K. et al. Impaired vasopressin secretion in patients with myotonic dystrophy // Nippon Naibunpi Gakkai Zasshi. 1988. V. 64. No 2. P. 69-77.
149. Iwasaki Y., Oiso Y., Yamauchi K. et al. Osmoregulation of plasma vasopressin in myxedema // J. Clin. Endocrinol. Metab. 1990. V. 70. No 2. P. 534-539.
150. Iwashima Y., Horio T., Takami Y. et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF // Am. J. Kidney Dis. 2002. V. 40. No 5. P. 974-982.
151. Jackson E.K. Vasopressin and other agents affecting the renal conservation of water // The pharmacological basis of therapeutics / Eds Hardman J.G., Goodman Gilman A., Limbird L.E. 9th ed. NY: McGraw Hill, 1995. P. 715-731.
152. Jacobson J., Bohn D. Severe hypernatremic dehydration and hyperkalemia in an infant with gastroenteritis secondary to rotavirus // Ann. Emerg. Med. 1993. V. 22. No 10. P. 1630-1632.
153. Jardine R.M., Obel I.W., Smith A.M. Intravenous acebutolol raises serum potassium in acute myocardial infarction // Eur. Heart J. 1986. V. 7. No 2. P. 140-145.
154. Kadekaro M., Summy-Long J.Y. Centrally produced nitric oxide and the regulation of body fluid and blood pressure homeostasis // Clin. Exp. Pharmacol. Physiol. 2000. V. 27. P. 450-459.
155. Kalff R., Houtkooper M.A., Meyer J.W. et al. Carbamazepine and serum sodium levels // Epilepsia. 1984. V. 25. No 3. P. 390-397.
156. Kamal S., Sharan A., Kumar U., Shahi S.K. Serum magnesium level in preterm labour // Indian J. Pathol. Microbiol. 2003. V. 46. No 2. P. 271-273.
157. Kamel K.S., Ethier J.H., Quaggin S. et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine // J. Am. Soc. Nephrol. 1992. V. 2. No 8. P. 1279-1284.
158. Karanikas G., Schutz M., Szabo M. et al. Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy // Am. J. Nephrol. 2004. V. 24. No 1. P. 41-45.
159. Kari J.A., Farouq M., Alshaya H.O. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis // Pediatr. Nephrol. 2003. V. 18. No 6. P. 506-510.
160. Kater C.E., Bigliery E.G., Schambelan M., Arteaga E. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatuos but not hyperplastic primary aldosteronism // Hypertension. 1983. V. 5. Suppl. No 6. P. V115-V121.
161. Kawabe H., Furukawa T., Saito I., Satura T. Importance of atrial natriuretic hormone in an exaggerated natriuresis during acute sodium load in primary aldosteronism // Acta Endocrinol. (Copenh). 1992. V. 126. No 1. P. 37-43.
162. Keilani T., Danesh F.R., Schlueter W.A. et al. A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium // Am. J. Kidney Dis. 1999. V. 33. No 3. P. 450-457.
163. Keitel H.Y. The concentration of potassium in the plasma // Arch. Dis. Child. 1959. V. 97. P. 583-589.
164. Kemper M.J., Harps E., Muller-Wiefel D.E. Hyperkalemia: therapeutic options in acute and chronic renal failure // Clin. Nephrol. 1996. V. 46. N. 1. P. 67-69.
165. Kemper M.J., Harps E., Hellwege H.H., Muller-Wiefel D.E. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol // Eur. J. Pediatr. 1996. V. 155. No 6. P. 495-497.
166. Kettleson M., Hurwitz S., Shah M.R. et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality // J. Am. Coll. Cardiol. 2003. V. 41. No 11. P. 2029-2035.
167. Kharasch E.D., Bowdle T.A. Hypokalemia before induction of anesthesia and prevention by beta 2 adrenoceptor antagonism // Anesth. Analg. 1991. V. 72. No 2. P. 216-220.
168. Kilbride H.W., Cater G., Warady B.A. Early onset hyperkalemia in extremely low birth weight infants // J. Perinatol. 1988. V. 8. No 3. P. 211-214.
169. Kim H.J. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients // Nephron. 1996. V. 72. No 3. P. 476-482.
170. Kimura T., Ota K., Shoji M. et al. Plasma vasopressin and atrial natriuretic hormone levels in hypopituitarism with and without hydrocortisone treatments: responses to an acute water load // Acta Endocrinol. (Copenh). 1992. V. 126. No 3. P. 217-223.
171. Kisters K., Tepel M., Spieker C. et al. Decreased cellular Mg2 + concentrations in a subgroup of hypertensives - cell models for the pathogenesis of primary hypertension // J. Hum. Hypertens. 1997. V. 11. No 6. P. 367-372.
172. Kiviranta T., Airaksinen E.M. Low sodium levels in serum are associated with subsequent febrile seizures // Acta Paediatr. 1995. V. 84. No 12. P. 1372-1374.
173. Kiviranta T., Tuomisto L., Airaksinen E.M. Osmolality and electrolytes in cerebrospinal fluid and serum of febrile children with and without seizures // Eur. J. Pediatr. 1996. V. 155. No 2. P. 120-125.
174. Klein C.J., Moser-Veillon P.B., Schweitzer A. et al. Magnesium, calcium, zinc, and nitrogen loss in trauma patients during continuous renal replacement therapy // J. Parenter. Enteral. Nutr. 2002. V. 26. No 2. P. 77-92.
175. Knight G., Jennings A.M., Boulton A.J.M. et al. Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump // BMJ. 1985. V. 291. No 6492. P. 371-372.
176. Ko G.T., Chow C.C., Yeung V.T. et al. Thyrotoxic periodic paralysis in a Chinese population // QJM. 1996. V. 89. No 6. P. 463-468.
177. Koch S.M., Mehlhorn U., Baggstrom E. et al. Hypercalcitoninemia and inappropriate calciuria in the acute trauma patient // J. Crit. Care. 1996. V. 11. No 3. P. 117-121.
178. Kohno S., Ogata K., Komiya T. et al. Hyponatremia in Duchenne muscular dystrophy on mechanical ventilation // Rinsho Shinkeigaku. 1998. V. 38. No 2. P. 107-111.
179. Koren-Michowitz M., Avni B., Michowitz Y. et al. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study // Pharmacoepidemiol. Drug Saf. 2004. V. 13. No 5. P. 299-302.
180. Kostis J.B., Lacy C.R., Hall W.D. et al. The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group // Am. J. Cardiol. 1994. V. 74. No 5. P. 464-467.
181. Koushanpour E., Kriz W. Renal physiology. N.Y.: Springer, 1986. 390 p.
182. Kovacs L., Lichardus B. Vasopressin: disturbed secretion and its effects. Dordrecht: Kluwer Acad. Publ., 1989. 296 p.
183. Kroenke K., Wood D.R., Hanley J.F. The value of serum magnesium determination in hypertensive patients receiving diuretics // Arch. Int. Med. 1987. V. 147. No 9. P. 1553-1556.
184. Kuehn E.W., Anders H.J., Bogner J.R. et al. Hypocalcaemia in HIV infection and AIDS // J. Int. Med. 1999. V. 245. No 1. P. 69-73.
185. Kurzel R.B. Serum magnesium levels in pregnancy and preterm labor // Am. J. Perinatol. 1991. V. 8. No 2. P. 119-127.
186. Lachaal M., Venuto R.C. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine // Am. J. Med. 1989.
187. Lahr M.B. Hyponatremia during carbamazepine therapy // Clin. Pharmacol. Ther. 1985. V. 37. No 6. P. 693-696.
188. Lai C.K., Legge J.S., Friend J.A. Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe? // Respiration. 1991. V. 58. No 5-6. P. 249-254.
189. Laitinen K., Lamberg-Allardt C., Tunninen R. et al. Transient hypoparathyroidism during acute alcohol intoxication // N. Engl. J. Med. 1991. V. 324. No 11. P. 721-727.
190. Lal J., Vasudev K., Kela A.K., Jain S.K. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus // J. Assoc. Physicians India. 2003. V. 51. P. 37-42.
191. Lambert R.C., Moos F.C., Richard P. Action of endogenous oxytocin within the paraventricular or supraoptic nuclei: a powerful link in the regulation of the bursting pattern of oxytocin neurons during milk-ejection reflex in rats // Neuroscience. 1993. V. 57. P. 1027-1038.
192. Langdahl B.L., Loft A.G., Eriksen E.F. et al. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy // Eur. J. Endocrinol. 1996. V. 134. No 6. P. 702-709.
193. Larach M.G., Rosenberg H., Gronert G.A., Allen G.C. Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies // Clin. Pediatr. (Phila). 1997. V. 36. No 1. P. 9-16.
194. Laso F.J., Gonzalez-Buitrago J.M., Martin-Ruiz C. et al. Inter-relationship between serum potassium and plasma catecholamines and 3′:5′ cyclic monophosphate in alcohol withdrawal // Drug Alcohol. Depend. 1990. V. 26. No 2. P. 183-188.
195. Lazar L., Erez I., Gutermacher M. et al. Brain concussion produces transient hypokalemia in children // J. Pediatr. 1997. V. 32. N. 1. P. 88-90.
196. Leach Huntoon C.S., Grigoriev A.I., Natochin Yu.V. Fluid and electrolyte regulation in spacefligth. San Diego: Am. Astron. Soc. Publ., 1998. 219 p.
197. Leal A.M., Elias P.C., Moreira A.C. Impairment of AVP regulation in 17alpha-hydroxylase deficiency, a unique form of adrenal insufficiency // J. Endocrinol. Invest. 2002. V. 25. No 7. P. 635-638.
198. Leanza H.J., Rivarola G., Graciela Garcia M. et al. Rapid correction of acute hyperkalemia with nebulized salbutamol // Medicina (B. Aires). 1992. V. 52. No 2. P. 99-102.
199. Lemieux G., Beauchemin M., Vinay P., Gougoux A. Hypokalemia during the treatment of arterial hypertension with diuretics // Can. Med. Assoc. J. 1980. V. 122. No 8. P. 905-907.
200. Leslie G.I., Carman G., Anold J.D. Early neonatal hyperkalaemia in the extremely premature newborn infant // J. Paediatr. Child. Health. 1990. V. 26. No 1. P. 58-61.
201. Levitan D., Massry S.G., Romoff M., Campese V.M. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine // Nephron. 1984. V. 36. No 1. P. 24-29.
202. Lin S.L., Kong M.S. Extremely low sodium hypotonic rehydration solution for young children with acute gastroenteritis // Chang Gung Med. J. 2001. V. 24. No 5. P. 294-299.
203. Lind L., Lithell H., Hvarfner A., Ljunghall S. Indices of mineral metabolism in subjects with an impaired glucose tolerance // Exp. Clin. Endocrinol. 1990. V. 96. No 1. P. 109-112.
204. Linko K., Saxelin I. Electrolyte and acid-base disturbances caused by blood transfusions // Acta Anaesthesiol. Scand. 1986. V. 30. No 2. P. 139-144.
205. Lins R.L., Daclemans R., Dratwa M. et al. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency // Am. J. Med. 1989. V. 87. No 3C. P. 41S-45S.
206. Lipworth B.J., McDevitt D.G., Struthers A.D. Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol // Am. J. Med. 1989. V. 86. No 6, Pt 1. P. 653-657.
207. Lo C.Y., Tam P.C., Kung A.W. et al. Primary aldosteronism. Results of surgical treatment // Ann. Surg. 1996. V. 224. No 2. P. 125-130.
208. Lorenz J.M., Kleinman L.I., Markarian K. Potassium metabolism in extremely low birth weight infants in the first week of life // J. Pediatr. 1997. V. 131. No 1. Pt. 1. P. 81-86.
209. Lucas N., Lopez-Herce J., Munoz M.A. et al. Normal values for serum, ultafilterable and intraerythrocytic magnesium in children // Magnes. Res. 2000. V. 13. No 2. P. 103-110.
210. Lui K., Thungappa U., Nair A., John E. Treatment with hypertonic dextrose and insulin in severe hyperkalaemia of immature infants // Acta Paediatr. 1992. V. 81. No 3. P. 213-216.
211. Lupton B.A., Roland E.H., Whitfield M.F., Hill A. Serum sodium concentration and intraventricular hemorrhage in premature infants // Am. J. Dis. Child. 1990. V. 144. No 9. P. 1019-1021.
212. Luu M., Stevenson W.G., Stevenson L.W. et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure // Circulation. 1989. V. 80. No 6. P. 1675-1680.
213. Ma J.T., Wang C., Lam K.S. et al. Fifty cases of primary hyperaldosteronism in Hong Kong Chinese with a high frequency of periodic paralysis. Evaluation of techniques for tumour localisation // QJM. 1986. V. 61. No 235. P. 1021-1037.
214. Madias J.E., Madias N.E., Gavras H.P. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension // Arch. Int. Med. 1984. V. 144. No 11. P. 2171-2176.
215. Madias J.E., Shah B., Chintalapally G. et al. Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of inhospital outcome // Chest. 2000. V. 118. No 4. P. 904-913.
216. Madias J.E., Sheth K., Choudry M.A. et al. Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction // Arch. Int. Med. 1996. V. 156. No 15. P. 1701-1708.
217. Mahajan S.K., Mangla M., Kishore K. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients // J. Assoc. Physicians India. 2001. V. 49. P. 1082-1085.
218. Malone D.R., McNamara R.M., Malone R.S. et al. Hypokalemia complicating emergency fluid resuscitation in children // Pediatr. Emerg. Care. 1990. V. 6. No 1. P. 13-16.
219. Mannix E.T., Farber M.O., Aronoff G.R. et al. Hemodynamic, renal and hormonal responses to lower body positive pressure in human subjects // J. Lab. Clin. Med. 1996. V. 128. No 6. P. 585-593.
220. Manoukian M.A., Foote J.A., Crapo L.M. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes // Arch. Intern. Med. 1999. V. 159. No 6. P. 601-606.
221. Marangoni E., Oddone A., Surian M. et al. Effect of high-dose furosemide in refractory congestive heart failure // Angiology. 1990. V. 41. No 10. P. 862-868.
222. Markell M.S., Altura B.T., Barbour R.L., Altura B.M. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels // Clin. Sci. (L.). 1993. V. 85. No 3. P. 315-318.
223. Markell M.S., Altura B.T., Sarn Y. et al. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis // ASAIO J. 1993. V. 39. No 3. P. M801-M804.
224. Martin G.B., Nowak R.M., Cisek J.E. et al. Hyperkalemia during human cardiopulmonary resuscitation: incidence and ramifications // J. Emerg. Med. 1989. V. 7. No 2. P. 109-113.
225. Martina B., Staubli M. Zur Hypokaliamie beim akuten Herzinfarkt // Schweiz. Med. Wochenschr. 1987. V. 117. No 49. P. 1957-1959.
226. Martinez Vea A., Montoliu J., Andreu L. et al. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia // Proc. Eur. Dial. Transplant. Assoc. 1983. V. 19. P. 756-760.
227. Mathialahan T., Sandle G.I. Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease // Nephrol. Dial. Transplant. 2003. V. 18. No 2. P. 341-347.
228. Mazzaferro S., Barberi S., Scarda A. et al. Ionised and total serum magnesium in renal transplant patients // J. Nephrol. 2002. V. 15. No 3. P. 275-280.
229. McKenna K., Morris A.D., Azam H. et al. Exaggerated vasopressin secretion and attenuated osmoregulated thirst in human survivors of hyperosmolar coma // Diabetologia. 1999. V. 42. No 5. P. 534-538.
230. McKinley M.J. Thirst: Physiological Aspects. L.: Springer-Verlag, 1991.
231. McKinley M.J., Denton D.A., Weisinger R.S. Sensors for antidiuresis and thirst-osmoreceptors or CSR sodium detectots? // Brain Res. 1978. V. 141. P. 89-103.
232. McNair P., Madsbad S., Christiansen C. et al. Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients // Clin. Chim. Acta. 1982. V. 120. No 2. P. 243-250.
233. McQuillen K.K.; Anderson A.C. Osmol gaps in the pediatric population // Acad. Emerg. Med. 1999. V. 6. N. 1. P. 27-30.
234. Meema H.E., Oreopoulos D.G., Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease // Kidney Int. 1987. V. 32. No 3. P. 388-394.
235. Mehta K.C., Kalkwarf H.J., Mimouni F. et al. Randomized trial of magnesium administration to prevent hypocalcemia in infants of diabetic mothers // J. Perinatol. 1998. V. 18. N. 5. P. 352-356.
236. Melzi M.L., Guez S., Sersale G. et al. Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations // Pediatr. Infect. Dis. J. 1995. V. 14. No 1. P. 56-59.
237. Mena P., Maynar M., Moreno J.M. et al. Hiperpotasemia y sus consecuencias electrocardiograficas en ciclistas profesionales al final de una vuelta ciclista // Rev. Esp. Fisiol. 1993. V. 49. No 1. P. 55-58.
238. Mencia S., Lucas N., Lopez-Herce J. et al. Magnesium metabolism after cardiac surgery in children // Pediatr. Crit. Care Med. 2002. V. 3. No 2. P. 158-162.
239. Migdalis I.N., Xenos K., Chairopoulos K. et al. Ca(2+)-Mg(2+)-ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy // Diabetes Res. Clin. Pract. 2000. V. 49. No 2-3. P. 113-118.
240. Mimouni F., Loughead J., Miodovnik M. et al. Early neonatal predictors of neonatal hypocalcemia in infants of diabetic mothers: an epidemiologic study // Am. J. Perinatol. 1990. V. 7. No 3. P. 203-206.
241. Mimouni F., Loughead J.L., Tsang R.C., Khoury J. Postnatal surge in serum calcitonin concentrations: no contribution to neonatal hypocalcemia in infants of diabetic mothers // Pediatr. Res. 1990. V. 28. No 5. P. 493-497.
242. Minaker K.L., Meneilly G.S., Flier J.S., Rowe J.W. Insulin-mediated hypokalemia and paralysis in familial hypokalemic periodic paralysis // Am. J. Med. 1988. V. 84. No 6. P. 1001-1006.
243. Moir C.L., Mandin H., Brant R. Sorbitol 2.5% mannitol 0.54% irrigation solution for hysteroscopic endometrial ablation surgery // Can. J. Anaesth. 1997. V. 44. No 5, Pt 1. P. 473-478.
244. Montenegro J., Gonzalez O., Saracho R. et al. Changes in renal function in primary hypothyroidism // Am. J. Kidney Dis. 1996. V. 27. No 2. P. 195-198.
245. Montoliu J., Almirall J., Ponz E. et al. Treatment of hyperkalaemia in renal failure with salbutamol inhalation // J. Intern. Med. 1990. V. 228. No 1. P. 35-37.
246. Montoliu J., Lens X.M., Revert L. Potassium-lowering effect of albuterol for hyperkalemia in renal failure // Arch. Intern. Med. 1987. V. 147. No 4. P. 713-717.
247. Mooser V., Fellay G., Regamey C. Hyperkaliemie lors d'inhibition prolongee de l'enzyme de conversion de l'sangiotensine II dans l'insuffisance renale terminale// Schweiz. Med. Wochenschr. 1992. V. 122. No 50. P. 1927-1929.
248. Mor J., Ben Galim E., Abrahamov A. Inappropriate antidiuretic hormone secretion in an infant with severe pneumonia // Am. J. Dis. Child. 1975. V. 129. No 1. P. 133-135.
249. Morgan T., Myers J. Potassium maintenance, potassium supplements or potassium sparing agents // Acta Med. Scand. 1980. V. 647, suppl. No 7. P. 117-123.
250. Mousa D., Rassoul Z., Popovich W. et al. A new treatment for Interdialytic hyperkalemia - the use of fosinopril sodium // Am. J. Nephrol. 1999. V. 19. Noa 3. P. 395-399.
251. Moylan F.M., Herrin J.T., Krishnoothy K. et al. Inappropriate antidiuretic hormone secretion in premature infants with cerebral injury // Am. J. Dis. Child. 1978. V. 132. No 4. P. 399-402.
252. Mulkerrin E., Epstein F.H., Clark B.A. Aldosterone responses to hyperkalemia in healthy elderly humans // J. Am. Soc. Nephrol. 1995. V. 6. No 5. P. 1459-1462.
253. Murtaza A., Khan S.R., Butt K.S. et al. Paralytic ileus, a serious complication in acute diarrhoea disease among infants in developing countries // Acta Paediatr. Scand. 1989. V. 78. No 5. P. 701-705.
254. Muther R.S., McCarron D.A., Bennett W.M. Change in serum bicarbonate during acute EDTA infusions in post-transplant hyperparathyroidism // Nephron. 1982. V. 30. No 1. P. 36-38.
255. Nader P.J., Procianoy R.S. Hyperkalemia in very low birthweight infants: incidence and associated factors // J. Pediatr. (Rio J). 1996. V. 72. No 3. P. 143-150.
256. Nakazato Y., Shimazu K., Tamura N. et al. Pseudohyperkalemia in myotonic dystrophy // Rinsho Shinkeigaku. 1993. V. 33. No 10. P. 1097-1099.
257. Namias B., Soupart A., Kornreich A., Decaux G. In human patients, vascular water retention during DDAVP-related hyponatremia occurs mainly in the plasma volume and not in the erythrocyte // J. Lab. Clin. Med. 1996. V. 128. No 6. P. 612-617.
258. Nathoo K.J., Porteous J.E., Siziya S. et al. Predictors of mortality in children hospitalized with dysentery in Harare Zimbabwe // Cent. Afr. J. Med. 1998. V. 44. No 11. P. 272-276.
259. Navarro J.F., Macia M.L., Gallego E. et al. Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? // Scand. J. Urol. Nephrol. 1997. V. 31. No 3. P. 275-280.
260. Navarro J.F., Mora C., Jimenez A. et al. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients // Am. J. Kidney Dis. 1999. V. 34. No 1. P. 43-48.
261. Navarro J.F., Mora C., Macia M., Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients // Perit. Dial. Int. 1999. V. 19. No 5. P. 455-461.
262. Navarro J.F., Mora C., Rivera A. et al. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration // Am. J. Kidney Dis. 1999. V. 33. No 3. P. 458-463.
263. Netten P.M., de Mulder P.H., Theeuwes A.G. et al. Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemia // Ann. Oncol. 1990. V. 1. No 5. P. 369-372.
264. Newnham D.M., McDevitt D.G., Lipworth B.J. The effects of frusemide and triamterene on the hypokalaemic and electrocardiographic responses to inhaled terbutaline // Br. J. Clin. Pharmacol. 1991. V. 32. No 5. P. 630-632.
265. Nigam P., Dayal S.G., Sriwastava P., Joshi L.D. Serum calcium and magnesium in leprosy // Asian J. Infect. Dis. 1979. V. 3. No 2. P. 81-83.
266. Nigam P., Mukhija R.D., Agrawal A.K. et al. Serum cations (calcium and magnesium) in leprosy // Indian J. Lepr. 1985. V. 57. No 3. P. 529-533.
267. Noakes T.D., Wilson G., Gray D.A. et al. Peak rates of diuresis in healthy humans during oral fluid overload // S. Afr. Med. J. 2001. V. 91. No 10. P. 852-857.
268. Noormohamed F.H., Youle M.S., Tang B. et al. Foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patients // Antivir. Ther. 1996. V. 1. No 3. P. 172-179.
269. Nowicki M., Szewczyk-Seifert G., Klimek D., Kokot F. Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patients // Clin. Nephrol. 2002. V. 57. No 5. P. 352-358.
270. Nowicki M., Walus T., Kokot F. Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients // Kidney Blood Press Res. 2002. V. 25. No 1. P. 55-60.
271. Nussey S.S., Ang V.T.Y., Bevan D.H., Jenkins J.S. Human platelet arginine vasopressin // Clin. Endocrinol. (Oxf). 1986. V. 24. No 4. P. 427-433.
272. Oladipo O.O., Ajala M.O., Okubadejo N. et al. Plasma magnesium in adult Nigerian patients with epilepsy // Niger. Postgrad. Med. J. 2003. V. 10. No 4. P. 234-237.
273. Oladipo O.O., Chukwu C.C., Ajala M.O. et al. Plasma magnesium in adult asthmatics at the Lagos University Teaching Hospital, Nigeria // East Afr. Med. J. 2003. V. 80. No 9. P. 488-491.
274. Omar S.A., DeCristofaro J.D., Agarwal B.I., LaGamma E.F. Effect of prenatal steroids on potassium balance in extremely low birth weight neonates // Pediatrics. 2000. V. 106. No 3. P. 561-567.
275. Owada A., Tomita K., Ujiie K. et al. Decreased lithium clearance in patients with hyperthyroidism // Nephron. 1993. V. 64. No 1. P. 37-41.
276. Padhani A., Turaihi K., Junglee D. et al. Increase in plasma potassium concentration following indomethacin administration: absence of a role for membrane NaK ATPase // Agents Actions. 1987. V. 22. No 1-2. P. 131-133.
277. Padilla G., Ervin M.G., Ross M.G., Leake R.D. Vasopressin leves in infants during the course of aseptic and bacterial meningitis. // Am. J. Dis. Child. 1991. V. 145. P. 991-993.
278. Padilla G., Leake J.A., Castro R. et al. Vasopressin levels and pediatric head trauma // Pediatrics. 1989. V. 83. No 5. P. 700-705.
279. Papademetriou V., Burris J.F., Notargiacomo A. et al. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension // Arch. Intern. Med. 1988. V. 148. No 6. P. 1272-1276.
280. Papademetriou V., Notargiacomo A., Heine D. et al. Effects of diuretic therapy and exercise-related arrhythmias in systemic hypertension // Am. J. Cardiol. 1989. V. 64. No 18. P. 1152-1156.
281. Papageorgiou A.N., Moffatt M. Bilateral pneumonia and inappropriate secretion of antidiuretic hormone in a premature infant // Can. Med. Assoc. J. 1976. V. 114. No 12. P. 1119-1120.
282. Pascual E.E., Cintron G.B., Valdez M.G., Clark P.I. Effect of diuretic therapy on the electrocardiographic response to exercise // Clin. Cardiol. 1992. V. 15. No 2. P. 93-94.
283. Paterna S., Di Pasquale P., Parrinello G. et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure // Eur. J. Heart Fail. 2000. V. 2. No 3. P. 305-313.
284. Pedrozzi N.E., Truttmann A.C., Faraone R. et al. Circulating ionized and total magnesium in end-stage kidney disease // Nephron. 1998. V. 79. No 3. P. 288-292.
285. Pendlebury S.C., Moses D.K., Eadie M.J. Hyponatraemia during oxcarbazepine therapy // Hum. Toxicol. 1989. V. 8. No 5. P. 337-344.
286. Perez-Ayuso R.M., Arroyo V., Camps J. et al. Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics // Nephron. 1984. V. 36. No 1. P. 30-37.
287. Perez-Perez A.J., Pazos B., Sobrado J. et al. Acute renal failure following massive mannitol infusion // Am. J. Nephrol. 2002. V. 22. No 5-6. P. 573-575.
288. Perseghin P., Confalonieri G., Buscemi F. et al. Electrolyte monitoring in patients undergoing peripheral blood stem cell collection // J. Clin. Apheresis. 1999. V. 14. No 1. P. 14-17.
289. Pillans P.I., Coulter D.M. Fluoxetine and hyponatraemia-a potential hazard in the elderly // N. Z. Med. J. 1994. V. 107. No 973. P. 85-86.
290. Pitkin R.M., Cruikshank D.P., Schauberger Ch.W. et al. Fetal calcitropic hormones and neonatal calcium homeostasis // Pediatrics. 1980. V. 66. No 2. P. 77-82.
291. Plante G.E., Dessurault D.L. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide // Am. J. Med. 1988. V. 84. No 1B. P. 98-103.
292. Poddar U., Singhi S., Ganguli N.K., Sialy R. Water electrolyte homeostasis in acute bronchiolitis // Indian Pediatr. 1995. V. 32. No 1. P. 59-65.
293. Polderman K.H., Bloemers F.W., Peerdeman S.M., Girbes A.R. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury // Crit. Care Med. 2000. V. 28. No 6. P. 2022-2025.
294. Polderman K.H., Peerdeman S.M., Girbes A.R. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury // J. Neurosurg. 2001. V. 94. No 5. P. 697-705.
295. Pomeranz S., Constantini S., Rappaport Z.H. Hypokalaemia in severe head trauma // Acta Neurochir. (Wien). 1989. V. 97. No 1-2. P. 62-66.
296. Prabha M.R., Pereira P., Chowta N., Hegde B.M. Clinical implications of hypocalcemia in malaria // Indian J. Med. Res. 1998. V. 108. P. 62-65.
297. Prasad S.V., Singhi S., Chugh K.S. Hyponatremia in sick children seeking pediatric emergency care // Indian. Pediatr. 1994. V. 31. No 3. P. 287-294.
298. Na test is of no prognostic value in acute renal failure // Nephron. 1984. V. 36. No 1. P. 20-23.
299. Quarello F., Guarena C., Boero R. et al. Erythrocyte Na-stimulated Mg transport in uremic patients undergoing CAPD // Adv. Perit. Dial. 1990. V. 6. P. 207-210.
300. Quionones Galvan A., Natali A., Muscelli E. et al. Insulin sensitivity in cardiological syndrome X // J. Intern. Med. 1996. V. 239. No 3. P. 241-247.
301. Rado J., Toth A., Haris A. Az aldoszteron szerepe a kaliumkivalasztasban hypertensioval szovodott kronikus veseelegtelensegben (transtubularis kaliumgradiens) // Orv. Hetil. 1997. V. 138. No 40. P. 2517-2520.
302. Rahman A.R., McDevitt D.G., Struthers A.D., Lipworth B.J. The effects of enalapril and spironolactone on terbutaline-induced hypokalemia // Chest. 1992. V. 102. No 1. P. 91-95.
303. Rama R., Ibanez J., Riera M. et al. Hematological, electrolyte, and biochemical alterations after a 100-km run // Can. J. Appl. Physiol. 1994. V. 19. No 4. P. 411-420.
304. Ramirez G., Brueggemeyer C.D., Newton J.L. Cardiac arrhythmias on hemodialysis in chronic renal failure patients // Nephron. 1984. V. 36. No 4. P. 212-218.
305. Raml A., Schmekal B., Grafinger P., Biesenbach G. Hyperkaliamierisiko unter Langzeittherapie mit ACE-Hemmem bei insulinpflichtigen Typ-2-Diabetikern in Abhangigkeit von der GFR // Dtsch. Med. Wochenschr. 2001. V. 126. No 47. P. 1327-1330.
306. Ramos E.L., Barri Y.M., Kubilis P. et al. Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels // Clin. Transplant. 1995. V. 9. No 3, Pt 1. P. 185-189.
307. Rasmussen H.S., Suenson M., McNair P. et al. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study // Clin. Cardiol. 1987. V. 10. No 6. P. 351-356.
308. Rees L., Brook C.G., Shaw J.C., Forsling M.L. Hyponatraemia in the first week of life in preterm infants. Part I. Arginine vasopressin secretion // Arch. Dis. Child. 1984. V. 59. No 5. P. 414-422.
309. Reid J.L., Whyte K.F., Struthers A.D. Epinephrin-induced hypokalemia: the role of beta adrenoreceptors // Am. J. Cardiol. 1986. V. 57. No 12. P. 23F-27F.
310. Reidenberg M.M., Gu Z.P., Lorenzo B. et al. Differences in serum potassium concentrations in normal men in different geographic locations // Clin. Chem. 1993. V. 39. No 1. P. 72-75.
311. Resnick L.M., Laragh J.H. Calcium metabolism and parathyroid function in primary aldosteronism // Am. J. Med. 1985. V. 78. No 3. P. 385-390.
312. Reznick R.K., Langer B., Taylor B.R. et al. Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting // Gastroenterology. 1983. V. 84. No 4. P. 713-718.
313. Riggs J.E., Griggs R.C., Moxley R.T., Lewis E.D. Acute effects of acetazolamide in hyperkalemic periodic paralysis // Neurology. 1981. V. 31. No 6. P. 725-729.
314. Riikonen P., Saarinen U.M., Perkkio M. et al. Changing pattern of treatment policies invalidates the use of C-reactive protein level and hyponatremia as indicators of sepsis in children with malignancies // Pediatr. Hematol. Oncol. 1992. V. 9. No 4. P. 365-372
315. Rivers R.P., Forsling M.L., Olver R.P. Inappropriate secretion of antidiuretic hormone in infants with respiratory infections // Arch. Dis. Child. 1981. V. 56. No 5. P. 358-363.
316. Robert U. The respiratory distress synrom of prematurity // Pediatrics. 1959. V. 24. No 4. P. 562-568.
317. Robertson G.L., Athar S., Shelton R.L. Osmotic control of vasopressin function // Disturbances in body fluid osmotality / Ed. Andreoli T.A., Grantham J.J., Rector F.C., Jr. Bethesda, Maryland: Amer. Physiol. Soc., 1977. P. 125-148.
318. Rodrigues T., Macieira L., Alfaiate A. et al. Hipertensao e bem-estar: estudo com indapamida // Rev. Port. Cardiol. 1994. V. 13. No 1. P. 21-28.
319. Rodriguez-Moran M., Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes // Arch. Med. Res. 2001. V. 32. No 4. P. 300-303.
320. Rosenstock J., Loizou S.A., Brajkovich I.E. et al. Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes // Diabetologia. 1982. V. 22. No 3. P. 184-187.
321. Roy R.N., Chance G.W., Radde I.C. et al. Late hyponatremia in very low birthweight infants (less than 1.3 kilograms) // Pediatr. Res. 1976. V. 10. No 5. P. 526-531.
322. Ruiz-Beltran R., Herrero-Herrero J.I., Macias J.F. Mechanism of low serum sodium levels in Mediterranean spotted fever // Acta Trop. 1991. V. 50. No 2. P. 161-167.
323. Ruml L.A., Pak C.Y. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss // Am. J. Kidney Dis. 1999. V. 34. No 1. P. 107-113.
324. Rutkowski P., Tylicki L., Renke M. et al. Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis // Am. J. Kidney Dis. 2004. V. 43. No 2. P. 260-268.
325. Ryan M.P., Ryan M.F., Counihan T.B. The effect of diuretics on lymphocyte magnesium and potassium // Acta Med. Scand. 1980. V. 647. Suppl. No 7. P. 153-161.
326. Ryzen E., Servis K.L., Rude R.K. Effect of intravenous epinephrine on serum magnesium and free intracellular red blood cell magnesium concentrations measured by nuclear magnetic resonance // J. Am. Coll. Nutr. 1990. V. 9. No 2. P. 114-119.
327. Saavedra J.M. Brain and pituitary angiotensin // Endocr. Rev. 1992. V. 13. P. 329-380.
328. Saeed M.A. Severe hypematraemia in a very preterm infant // J. Pak. Med. Assoc. 1991. V. 41. Noa 7. P. 176-177.
329. Saha H., Harmoinen A., Nisula M., Pasternack A. Serum ionized versus total magnesium in patients with chronic renal disease // Nephron. 1998. V. 80. No 2. P. 149-152.
330. Saha H., Harmoinen A., Pietila K. et al. Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients // Clin. Nephrol. 1996. V. 46. No 5. P. 326-331.
331. Saha H.H., Harmoinen A.P., Pasternack A.I. Measurement of serum ionized magnesium in CAPD patients // Perit. Dial. Int. 1997. V. 17. No 4. P. 347-352.
332. Saito T., Higashiyama M., Nakamura T. et al. Urinary excretion of the aquaporin-2 water channel exaggerated in pathological states of impaired water excretion // Clin. Endocr. 2001. V. 55. P. 217-221.
333. Salerno D.M., Asinger R.W., Elsperger J. et al. Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction // Am. J. Cardiol. 1987. V. 59. No 1. P. 84-88.
334. Salerno D.M., Dunbar D., Sharkey P. Hypokalemia after cardioversion from ventricular tachycardia induced in the electrophysiology laboratory // Am. Heart J. 1987. V. 114. No 6. P. 1389-1395.
335. Salle B., David L., Glorieux F. et al. Hypocalcemia in infants of diabetic mothers. Studies in circulating calciotropic hormone concentrations // Acta Paediatr. Scand. 1982. V. 71. No 4. P. 573-577.
336. Sangal A.K., Kevwitch M., Rao D.S., Rival J. Hypomagnesemia and hypertension in primary hyperparathyroidism // South. Med. J. 1989. V. 82. No 9. P. 1116-1118.
337. Sassano P., Chatellier G., Alhenc-Gelas F. et al. Predictibilite et prevention de l'hypokaliemie induite par l'hydrochlorothiazide // Arch. Mal. Coeur. Vaiss. 1985. V. 78. No 11. P. 1667-1671.
338. Sassano P., Chatellier G., Billaud E. et al. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril // Am. J. Med. 1987. V. 83. No 2. P. 227-235.
339. Satur C.M., Stubington S.R., Jennings A. et al. Magnesium flux during and after open heart operations in children // Ann. Thorac. Surg. 1995. V. 59. No 4. P. 921-927.
340. Saudan P., Mach F., Perneger T. et al. Safety of low-dose spironolactone administration in chronic haemodialysis patients // Nephrol. Dial. Transplant. 2003. V. 18. No 11. P. 2359-2363.
341. Schafer G.E., Werner E. Der Einfluss von Bemetizid/Triamteren auf das Serum- und Gesamtkorperkalium bei Hochdruckkranken // MMW Munch. Med. Wochenschr. 1978. V. 120. No 45. P. 1505-1507.
342. Schepkens H., Vanholder R., Billioutw J.M., Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases // Am. J. Med. 2001. V. 110. No 6. P. 438-441.
343. Schmidli R.S., Wilson I., Espiner E.A. et al. Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status // Clin. Endocrinol. (Oxf). 1990. V. 32. No 3. P. 293-300.
344. Schmidt A., Gruber U., Bohmig G. et al. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA // Nephrol. Dial. Transplant. 2001. V. 16. No 5. P. 1034-1037.
345. Schmidt W., Rojas J., Boning D. et al. Plasma-electrolytes in natives to hypoxia after marathon races at different altitudes // Med. Sci. Sports Exerc. 1999. V. 31. No 10. P. 1406-1413.
346. Schnack C., Podolsky A., Watzke H. et al. Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia // Am. Rev. Respir. Dis. 1989. V. 139. No 1. P. 176-180.
347. Schwarz P., Sorensen H.A., Momsen G. et al. Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study // Acta Endocrinol. (Copenh). 1992. V. 126. No 3. P. 260-263.
348. Scott S.M., Ladenson J.H., Aguanna J.J. et al. Effect of calcium therapy in the sick premature infant with early neonatal hypocalcemia // J. Pediatr. 1984. V. 104. No 5. P. 747-751.
349. Shah G.M., Winer R.L., Cutler R.E. et al. Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis // Am. J. Kidney Dis. 1987. V. 10. No 4. P. 268-275.
350. Shann F., Germer S. Hyponatraemia associated with pneumonia or bacterial meningitis // Arch. Dis. Child. 1985. V. 60. No 10. P. 963-966.
351. Shannon M., Lovejoy F.H., Jr. Hypokalemia after theophylline intoxication. The effects of acute vs chronic poisoning // Arch. Intern. Med. 1989. V. 149. No 12. P. 2725-2729.
352. Share L. Role of vasopressin in cardiovascular regulation // Physiol. Rev. 1988. V. 68. P. 1248-1284.
353. Sharma S.K., Singh R., Patney N.L. et al. Serum magnesium levels in chronic renal failure. Clinical significance and correlation with sodium potassium and calcium // J. Assoc. Physicians India. 1990. V. 38. No 8. P. 569-571.
354. Sharples P.M., Seckl J.R., Human D. et al. Plasma and cerebrospinal fluid arginine vasopressin in patients with and without fever // Arch. Dis. Child. 1992. V. 67. No 8. P. 998-1002.
355. Sharwood K., Collins M., Goedecke J. et al. Weight changes, sodium levels, and performance in the South African Ironman Triathlon // Clin. J. Sport Med. 2002. V. 12. No 6. P. 391-399.
356. Sherman T.G., Day R., Civelli O. et al. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge // J. Neurosci. 1988. V. 8. P. 3785-3796.
357. Shortland D., Trounce J.Q., Levene M.I. Hyperkalaemia, cardiac arrhythmias, and cerebral lesions in high risk neonates // Arch. Dis. Child. 1987. V. 62. No 11. P. 1139-1143.
358. Singh D.S., Patwari A.K., Deb M. Cerebrospinal fluid osmolal changes in bacterial meningitis // Indian. Pediatr. 1993. V. 30. No 10. P. 1193-1197.
359. Singh B.S., Patwari A.K., Deb M. Serum sodium and osmolal changes in tuberculous meningitis // Indian. Pediatr. 1994. V. 31. No 11. P. 1345-1350.
360. Singh B.S., Sadiq H.F., Noguchi A., Keenan W.J. Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates // J. Pediatr. 2002. V. 141. No 1. P. 16-20.
361. Singhal P.C., Abramovici M., Ayer S., Desroches L. Determinants of rhabdomyolysis in the diabetic state // Am. J. Nephrol. 1991. V. 11. No 6. P. 447-450.
362. Singhal P.C., Abramovici M., Venkatesan J. Rhabdomyolysis in the hyperosmolal state // Am. J. Med. 1990. V. 88. No 1. P. 9-12.
363. Singhal P.C., Desroches L., Mattana J. et al. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease // Am. J. Nephrol. 1993. V. 13. No 2. P. 138-141.
364. Singhi S., Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia // Indian. Pediatr. 1992. V. 29. No 6. P. 735-740.
365. Singhi S.C., Jayashree K., Sarkar B. Hypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma // J. Paediatr. Child. Health. 1996. V. 32. No 6. P. 495-497.
366. Skinner A.L., Moll F.C. Hypematraemia accompanying infant diarrhea // Am. J. Dis. Child. 1956. V. 96. No 6. P. 562-587.
367. Skosky W.R., Kikuchi T.A. The role of vasopressin in the impaired water excretion of myxedema // Am. J. Med. 1978. V. 64. No 4. P. 613-621.
368. Smith H.W. The kidney. Structure and function in health and disease. N.Y.: Oxford Univ. Press, 1951. 1050 p.
369. Soliman A.T., al-Salmi I., Asfour M. Mode of presentation and progress of childhood diabetes mellitus in the Sultanate of Oman // J. Trop. Pediatr. 1997. V. 43. No 3. P. 128-132.
370. Speedy D.B., Campbell R., Mulligan G. et al. Weight changes and serum sodium concentrations after an ultradistance multisport triathlon // Clin. J. Sport Med. 1997. V. 7. No 2. P. 100-103.
371. Speedy D.B., Noakes T.D., Rogers I.R. et al. Hyponatremia in ultradistance triathletes // Med. Sci. Sports Exerc. 1999. V. 31. No 6. P. 809-815.
372. Steele A., Gowrishankar M., Abrahamson S. et al. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination // Ann. Int. Med. 1997. V. 126. No 1. P. 20-25.
373. Stigant C.E., Cohen J., Vivera M., Zaltzman J.S. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy // Am. J. Kidney Dis. 2000. V. 35. No 1. P. 58-63.
374. Struthers A.D., Reid J.L. Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation // Clin. Endocrinol. (Oxf). 1984. V. 20. No 4. p. 409-414.
375. Struthers A.D., Reid J.L., Whitesmith R., Rodger J.C. Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium // Br. Heart J. 1983. V. 49. No 1. P. 90-93.
376. Struthers A.D., Whitesmith R., Reid J.L. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia // Lancet. 1983. V. 1. No 8338. P. 1358-1361.
377. Suzuki K., Kono N., Onishi T., Tarui S. The effect of hypermagnesaemia on serum immunoreactive calcitonin levels in normal human subjects // Acta Endocrinol. (Copenh). 1987. V. 116. No 2. P. 282-286.
378. Sychlowy A., van der Gaag H., Hannen-Hofheinz. Hyperkaliamie- lebensbedrohliche Fruhkomplikation asphyktischer Fruhgeborener // Monatsschr. Kinderheilkd. 1990. V. 138. No 2. P. 62-56.
379. Takahashi N., Hoshi J., Nishida H. Water balance, electrolytes and acid-base balance in extremely premature infants // Acta Paediatr. Jpn. 1994. V. 36. No 3. P. 250-255.
380. Takeuchi K., Inui M., Mori T. Influences of magnesium sulfate on maternal calcium metabolism in preterm labor // Nippon Sanka Fujinka Gakkai Zasshi. 1992. V. 44. No 11. P. 1443-1449.
381. Tejani A., Dobias B., Mahadevan R. Osmolar relationships in infantile dehydration // Am. J. Dis. Child. 1981. V. 135. No 11. P. 1000-1005.
382. Thomas D.J., Dove A.F., Alberti K.G. Metabolic effects of salbutamol infusion during premature labour // Br. J. Obstet. Gynaecol. 1977. V. 84. No 7. P. 497-499.
383. Thompson C.J., Burd J.M., Baylis P.H. Acute suppression of plasma vasopressin and thirst after drinking in hypernatremic humans // Am. J. Physiol. 1987. V. 252. No 6. Pt 2. P. R1138-R1142.
384. Thompson R.G., Cobb L.A. Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation // JAMA. 1982. V. 248. No 21. P. 2860-2863.
385. Thornton S.N., Nicolaidis S. Blood pressure effects of iontophoretically applied bioactive hormones in the anterior forebrain of the rat // Am. J. Physiol. Regul. Integr. Comp. Physiol. 1993. V. 265. P. R826-R833.
386. Thurzo V., Ertl T., Hartmann G., Gacs E. Prolactin and dopamine concentrations in the cerebrospinal fluid during the neonatal period // Acta Paediatr. Hung. 1992. V. 32. No 4. P. 299-307.
387. Tillman D.M., Semple P.F. Calcium and magnesium in essential hypertension // Clin. Sci. (L.). 1988. V. 75. No 4. P. 395-402.
388. Tolaymat A., al-Mousily F., Sleasman J. et al. Hyponatremia in pediatric patients with HIV-1 infection // South. Med. J. 1995. V. 88. No 10. P. 1039-1042.
389. Toujz R.M., Panz V., Milne F.J. Relations between magnesium, calcium, and plasma renin activity in black and white hypertensive patients // Miner. Electrolyte Metab. 1995. V. 21. No 6. P. 417-422.
390. Trump D.L. Serious hyponatremia in patients with cancer: management with demeclocycline // Cancer. 1981. V. 47. No 12. P. 2908-2912.
391. Tsang R.C., Brown D.R., I-Wen Chen. Oral calcium supplementation in premature and asphyxiated neonates // Pediatrics. 1976. V. 89. No 6. P. 673-677.
392. Tsang R.C., Chen I., hayes W. et al. Neonatal hypocalcemia in infants with birth asphyxia // J. Pediatr. 1980. V. 84. No 3. P. 428-433.
393. Tveskov C., Djurhuus M.S., Klitgaard N.A., Egstrup K. Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta 2-adrenergic stimulation with terbutaline in healthy subjects // Chest. 1994. V. 106. No 6. P. 1654-1659.
394. Vaamonde C.A., Sebastianelli M.J., Vaamonde L.S. et al. Impaired renal tubular reabsorption of sodium in hypothyroid man // J. Lab. Clin. Med. 1975. V. 85. No 3. P. 451-466.
395. Van der Merwe W.M., Rodger R.S., Grant A.C. et al. Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients // Nephrol. Dial. Transplant. 1990. V. 5. No 10. P. 874-877.
396. Van Gilst W.H., Tijssen J.G., van Es G.A., Lubsen J. Serum potassium values in relation to the use of diuretics in patients with unstable angina pectoris // Eur. Heart. J. 1988. V. 9. No 7. P. 795-799.
397. Van Ingen H.E., Huijgen H.J., Kok W.T., Sanders G.T. Analytical evaluation of Kone Microlyte determination of ionized magnesium // Clin. Chem. 1994. V. 40. No 1. P. 52-55.
398. Verive M.J., Irazuzta J., Steinhart C.M. et al. Evaluating the frequency rate of hypomagnesemia in critically ill pediatric patients by using multiple regression analysis and a computer-based neural network // Crit. Care Med. 2000. V. 28. No 10. P. 3534-3539.
399. Verney E.B. The antidiuretic hormone and factors which determine its release // Proc. Soc. Lond. B Biol. 1947. V. 135. P. 25-105.
400. Verza M., Cacciapuoti F., Spiezia R. et al. Effects of the angiotensin converting enzyme inhibitor enalapril compared with diuretic therapy in elderly hypertensive patients // J. Hypertens. Suppl. 1988. V. 6. No 1. P. S97-S99.
401. Vieweg W.V., Carey R.M., Godleski L.S. et al. The syndrome of psychosis, intermittent hyponatremia, and polydipsia: evidence for diurnal volume expansion // Psychiatr. Med. 1990. V. 8. No 4. P. 135-144.
402. Vieweg W.V., Hundley P.L., Godleski L.S. et al. Diurnal weight gain as a predictor of serum sodium concentration in patient with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) // Psychiatry Res. 1988. V. 26. No 3. P. 305-312.
403. Vieweg W.V., Robertson G.L., Godleski L.S., Yank G.R. Diurnal variation in water homeostasis among schizophrenic patients subject to water intoxication // Schizophr. Res. 1988. V. 1. No 5. P. 351-357.
404. Vieweg W.V., Weiss N.M., David J.J. et al. Tretment of psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) using lithium and phenytoin // Biol. Psychiatry. 1998. V. 23. No 1. P. 25-30.
405. Vieweg W.V., Wilkinson E.G., David J.J. et al. The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) // Psychiatr. Q. 1988. V. 59. No 1. P. 62-68.
406. Vigier R.O., Colombo S.M., Stoffel P.B. et al. Circulating sodium in acute meningitis // Am. J. Nephrol. 2001. V. 21. No 2. P. 87-90.
407. Villarino Rodriguez A., Garcia-Linares M.C., Garcia-Fernandez M.C., Garcia-Arias M.T. Evaluacion dietetica y parametros bioquimicos de minerales en un colectivo de ancianos de la provincia de Leon (Espana) // Nutr. Hosp. 2003. V. 18. No 1. P. 39-45.
408. Walters E.G., Hughes I.A. Hyponatraemia in diabetes without ketoacidosis // Arch. Dis. Child. 1984. V. 59. No 8. P. 785-786.
409. Wang S.J., Tsau Y.K., Lu F.L. et al. Hypovolemia and hypovolemic shock in children with nephrotic syndrome // Acta Paediatr. Taiwan. 2000. V. 41. No 4. P. 179-183.
410. Wannamethee G., Whincup P.H., Shaper A.G., Lever A.F. Serum sodium concentration and risk of stroke in middle-aged males // J. Hypertens. 1994. V. 12. No 8. P. 971-979.
411. Wannamethee S.G., Lever A.F., Shaper A.G., Whincup P.H. Serum potassium, cigarette smoking, and mortality in middle-aged men // Am. J. Epidemiol. 1997. V. 145. No 7. P. 598-606.
412. Wannasilp N., Poungvarin N., Pokum S. et al. Serum magnesium in Thai coronary artery disease patients // J. Med. Assoc. Thai. 2001. V. 84, Suppl. No 3. P. S645-S649.
413. Waters A.K. Increased vasopressin excretion in patients with hypothyroidism // Acta Endocrinol. (Copenh). 1978. V. 88. No 2. P. 285-290.
414. Wattad A., Chiang M.L., Hill L.L. Hyponatremia in hospitalized children // Clin. Pediatr. Phila. 1992. V. 31. No 3. P. 53-57.
415. Weinberger M.H., Grim C.E., Hollifield J.W. et al. Primary aldosteronism: diagnosis, localization and treatment // Ann. Intern. Med. 1979. V. 90. No 3. P. 386-395.
416. Weissberg N., Schwartz G., Shemesh O. et al. Serum and mononuclear cell potassium, magnesium, sodium and calcium in pregnancy and labour and their relation to uterine muscle contraction // Magnes Res. 1992. V. 5. No 3. P. 173-177.
417. Whitworth J.A., Saines D., Scoggins B.A. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man // Clin. Exp. Hypertens. A. 1984. V. 6. No 4. P. 795-809.
418. Wolfe C.L., Nibley C., Bhandari A. et al. Polymorphous ventricular tachycardia associated with acute myocardial infarction // Circulation. 1991. V. 84. No 4. P. 1543-1551.
419. Wong E.T., Freier E.F. The differential diagnosis of hypercalcemia // JAMA. 1982. V. 247. No 1. P. 75-80.
420. Wu C., Kenny M.A. Circulating total and ionized magnesium after ethanol ingestion // Clin. Chem. 1996. V. 42. No 4. P. 625-629.
421. Wuermser L.A., Reilly C., Poindexter J.R. et al. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia // Kidney Int. 2000. V. 57. No 2. P. 607-612.
422. Yamamoto T., Sasaki S. Aquaporins in the kidney: emerging new aspects // Kidney Int. 1998. V. 54. P. 1041-1051.
423. Yang C.T., Lin H.C., Lin M.C. et al. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease // Eur. J. Clin. Pharmacol. 1996. V. 49. No 5. P. 341-345.
424. Yang W.C., Huang T.P., Ho L.T. et al. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol // Miner. Electrolyte Metab. 1986. V. 12. No 3. P. 186-193.
425. 2O-enflurane anesthesia in patients on chronic hemodialysis // Masui. 1993. V. 42. No 3. P. 402-405.
426. Yukioka H., Kurita S., Fujimori M. Perioperative management of patients on maintenance hemodialysis: serum potassium and hemodynamic changes during anesthesia // Masui. 1992. V. 41. No 1. P. 33-36.
427. Zainal D. Renal tubular acidosis in Kelantan, Malaysia - a case review // Singapore Med. J. 1994. V. 35. No 3. P. 303-305.
428. Zanella M.T., Mattei E., Draibe S.A. et al. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure // Clin. Pharmacol. Ther. 1985. V. 38. No 6. P. 613-617.
429. Zehnder C., Blumberg A. Behandlung der Anamie von Hamodialysepatienten mit rekombinantem humanem Erythropoietin: Vor- und Nachteile // Schweiz. Med. Wochenschr. 1989. V. 119. No 9. P. 269-275.
430. Zehtabchi S., Sinert R., Rinnert S. et al. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia // Am. J. Hematol. 2004. V. 77. No 3. P. 215-222.
431. Zellweger U., Zaugg P.Y., Dambacher M. et al. Ersatz aluminimhaltiger Phosphatbinder bei Langzeit-Hamodialyse-Patienten durch Calcium- und Magnesiumcarbonat // Dtsch. Med. Wochenschr. 1989. V. 114. No 17. P. 659-664.
432. Zumkley H., Bertram H.P., Preusiser P. et al. Renal excretion of magnesium and trace elements during cisplatin treatment // Clin. Nephrol. 1982. V. 17. No 5. P. 254-257.